Home » Newsletters » BioWorld Asia

BioWorld Asia

April 24, 2000

View Archived Issues

Antisoma Stock Takes Hit Following Independent Study

CeNeS Buying Cambridge Neuro In All-Stock Deal Valued At $44M

Study Of Rare Disorder Provides Clues For New Cancer Therapies

French Researchers Say There Are Only About 30,000 Genes

Oxford GlycoSciences Issued Broad Patent On Proteomics

NicOx Reports Early Phase II Results, Starts Phase I Study

Watson, Arntzen Among Those Adding Input To Israeli Biotech

SkyePharma Changes Strategy, Plans More Development Work

ExonHit, Collaborators Identify Markers Linked To Hypoxia

Queensland Group Develops Genetic Test For Skin Cancer

Other News To Note

United Nations Takes Step Toward Labeling GM Food

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.